Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Published in Annals of the rheumatic diseases • Aug 1, 2016
Authors:,,
Valérie Devauchelle-Pensec
Jean Marie Berthelot
Divi Cornec
Abstract
BACKGROUND: Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events. OBJECTIVES: To evaluate the efficacy and safety of first-line tocilizumab in PMR. METHODS: In a prospective open-label study (ClinicalTrials.gov: NCT01713842), 20 glucocorticoid-free ...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!